Preventing breast cancer is an important goal in modern medicine. Doctors have long used medications to lower risk, especially for women who have a higher chance of developing the disease.
One of the most common drugs used for this purpose is tamoxifen, a treatment that has been around for many years. While it is effective, it can also cause side effects that make it difficult for some women to continue taking it.
Tamoxifen works by blocking certain hormone signals in the body. These signals, especially those related to estrogen, can help some breast cancers grow. By reducing this effect, tamoxifen lowers the risk that cancer will develop or return.
Even though it has helped many patients, the side effects can be challenging. Women often report symptoms like hot flashes and night sweats, which can feel similar to menopause. These symptoms can be strong enough to affect daily life and lead some women to stop treatment early.
Because of these challenges, scientists have been searching for a better alternative. A new study from Karolinska Institutet, published in the Journal of the National Cancer Institute, has explored a possible solution. The researchers focused on a compound called endoxifen, which is the active form of tamoxifen inside the body.
When a person takes tamoxifen, the body changes it into endoxifen, which then carries out most of the drug’s effects. The idea behind the study was simple: instead of giving tamoxifen, why not give endoxifen directly? This might allow for more predictable results and possibly fewer side effects.
To test this idea, the researchers conducted a study with 240 healthy women who had not yet reached menopause. The women were divided into groups and given either a placebo or a low dose of endoxifen, either 1 milligram or 2 milligrams per day, for six months. The researchers then used imaging to measure changes in breast density.
Breast density is a known risk factor for breast cancer. Women with higher breast density have a higher chance of developing the disease. If a treatment can reduce breast density, it may also lower cancer risk.
The results showed that even low doses of endoxifen were effective. The group taking 1 milligram saw a reduction in breast density of about 19 percent. The group taking 2 milligrams saw a reduction of about 26 percent. These results were similar to what has been seen with standard doses of tamoxifen.
However, the lower dose appeared to have an advantage. Women taking 1 milligram of endoxifen had very few serious side effects, and their experience was similar to those taking a placebo. In contrast, women taking 2 milligrams reported more symptoms such as hot flashes and night sweats.
These findings suggest that a lower dose of endoxifen may be enough to produce a helpful effect while reducing discomfort. This could make it easier for women to continue treatment and benefit from it over time.
The study is considered a proof-of-concept trial. This means it shows that the drug can produce the desired biological effect, but it does not yet prove that it will prevent breast cancer or reduce recurrence. More research is needed to confirm these outcomes.
From a scientific perspective, the study is important because it highlights a new way of thinking about treatment. Instead of increasing drug doses to achieve stronger effects, it may be possible to use lower doses more carefully to balance benefits and side effects.
At the same time, there are limitations. The study was relatively short, lasting only six months, and involved healthy participants rather than patients with cancer. Long-term studies will be needed to understand how endoxifen performs over time and whether it truly reduces cancer risk.
In summary, this research offers a hopeful step forward. It suggests that breast cancer prevention could become more personalized and easier to tolerate. While more evidence is needed, the idea of using lower doses of targeted treatments could change how doctors approach prevention in the future.
If you care about breast cancer, please read studies about how eating patterns help ward off breast cancer, and soy and plant compounds may prevent breast cancer recurrence.
For more health information, please see recent studies about how your grocery list can help guard against caner, and a simple way to fight aging and cancer.
Source: Karolinska Institutet.
